Physician profile
Kristopher Wolfe
NPI 1497137947
$4,120.84
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $664 · 2021: $1,041 · 2022: $1,045 · 2023: $571 · 2024: $28.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $631.64 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $434.98 | 2021-2023 | Vraylar, Ubrelvy, Qulipta |
| Amarin Pharma, INC. | $343.41 | 2019-2021 | |
| Pfizer INC. | $258.83 | 2020-2023 | |
| Amgen INC. | $201.98 | 2019-2022 | |
| Lilly USA, LLC | $189.53 | 2019-2023 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $169.86 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $150.13 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $148.81 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.31 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $112.58 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $112.12 | 2020-2023 | |
| Astellas Pharma US INC | $101.75 | 2019-2023 | Myrbetriq |
| Janssen Pharmaceuticals, INC | $86.35 | 2019-2023 | Spravato |
| Teva Pharmaceuticals USA, INC. | $82.33 | 2019-2023 | Austedo |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.